Emgality is a prescription medication used to prevent migraines in adults. It belongs to a class of drugs known as calcitonin gene-related peptide (CGRP) inhibitors. Emgality works by blocking the activity of CGRP, a protein that is believed to play a key role in the development of migraines.

Clinical studies have shown that Emgality can significantly reduce the frequency of migraine attacks in patients who suffer from chronic migraines. It is typically administered as a subcutaneous injection once a month, although your healthcare provider may adjust the dosing schedule based on your individual needs.

As with any medication, Emgality may cause side effects in some patients. The most common side effects reported with Emgality include injection site reactions, such as redness, swelling, or itching. Some patients may also experience constipation or allergic reactions to the medication.

It is important to discuss any potential side effects or concerns with your healthcare provider before starting Emgality. They can help determine if this medication is the right choice for you based on your medical history and individual needs.

Overall, Emgality has been shown to be an effective and well-tolerated treatment option for preventing migraines in adults. If you suffer from chronic migraines and have not found relief with other medications, Emgality may be worth considering as part of your treatment plan. Be sure to follow your healthcare provider’s instructions carefully and report any side effects or concerns promptly.